Skip to main content
. 2012 May 1;31(1):40. doi: 10.1186/1756-9966-31-40

Figure 3.

Figure 3

Suppressed tube formation of human microvessel by conditioned media from C4-2B cells treated with bevacizumab (right) or control IgG (left).